drugset
drugset / Trial / NCT00461422

Early Follicular Supplementation of Ganirelix in IVF 2004

NCT00461422 ↗

Phase 4 Completed 50 enrolled The Baruch Padeh Medical Center, Poriya Organon · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

Our goal was to investigate whether early follicular supplementation of the GnRH antagonist to the flexible GnRH antagonist protocol, has a potential to improve IVF-ET clinical results

Timeline

Start
2004-01
Primary completion
2007-06
Completion
2007-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ganirelix Protein / enzyme biologic 0.25 mg Subcutaneous

Indications

infertility disorder